MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31.

Income Overview

Net Income
-$6,202K
Unit: Thousand (K) dollars

Income Statement
2026-03-31
Research and development
1,854
Selling, general and administrative
3,780
Total operating expenses
5,634
Loss from operations
-5,634
Change in fair value of derivative liability
33
Interest income
24
Interest expense
648
Net other (expense) income
-591
Net loss from operations before discontinued operations
-6,225
Revenue
24
Cost of sales
3
Gross profit
21
Selling, general and administrative
-2
Total operating expenses
-2
Income (loss) from discontinued operations
23
Net loss
-6,202
Basic EPS
-2.23
Basic Average Shares
2,883,650
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Revenue$24K Selling, general andadministrative-$2K Gross profit$21K Total operatingexpenses-$2K Cost of sales$3K Net loss-$6,202K Income (loss) fromdiscontinued operations$23K Net loss fromoperations before...-$6,225K Loss from operations-$5,634K Net other (expense)income-$591K Change in fair value ofderivative liability$33K Interest income$24K Total operatingexpenses$5,634K Interest expense$648K Selling, general andadministrative$3,780K Research and development$1,854K

Valion Bio, Inc. (VBIO)

Valion Bio, Inc. (VBIO)